Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460440) titled 'SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier' on March 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: University of Utah
Condition:
Lung Cancer
Lung Nodule
Intervention:
Diagnostic Test: Platelet RNA-based assay
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 240
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07460440
Publis...